Search

link to homepage

Navigation and service


Clear View of Smallest Details

Forschungszentrum Jülich Receives 9.4 Tesla Magnet

[27. Mai 2008]

Joint Press Release by:
Forschungszentrum Jülich and Siemens

Jülich, May 27, 2008 - The largest magnet in the world for imaging techniques in brain research arrived at Forschungszentrum Jülich on 27 May. Once installed, it will have a field strength of 9.4 Tesla, which is almost 200,000 times the strength of the earth′s magnetic field. Brain researchers at Jülich plan to use the large-scale device, nicknamed "9point4", to visualize previously inaccessible structures and metabolic processes of the brain. The system was jointly developed by the Research Center and Siemens.

The magnet is the heart of a unique large-scale system, which will be set up in cooperation with Siemens. The system is expected to become operational in 2009 and will for the first time combine magnetic resonance imaging (MRI) at a field strength of 9.4 Tesla with positron emission tomography (PET). Simultaneous imaging with both devices will allow researchers to map the structures and metabolic processes of the brain in more detail than ever before in order to study the mechanisms associated with neurodegenerative diseases such as Alzheimer′s and Parkinson′s Disease. "More precise insights into pathological changes of the brain may help us delay the actual outbreak of the disease for years," explained Prof. Jon Shah, manager of the Jülich-based Magnetic Resonance Physics research team. "The potential savings for the healthcare system are enormous." Siemens and the German Federal Ministry for Education and Research (BMBF) have provided funding of 10 millionEuros each for the project.

The Chairman of the Management Board, Prof. Bachem, expressed his appreciation to both partners: "We are extremely pleased about the generous support of the Ministry for this pioneering project to address one of the greatest challenges our society is facing in decoding the cause of neurodegenerative diseases, and about this opportunity to demonstrate, jointly with our long-standing partner Siemens, how to transfer basic research to practical applications with beneficial results."

"Siemens and the Forschungszentrum Jülich are strategic partners in a number of research activities that focus on energy and health. The 9.4 Tesla project is an excellent example of combining the outstanding expertise of Jülich with the technological strengths of the integrated Siemens Group for maximum patient benefit," commented Dr. Michael Kassner, Regional Head North Rhine of Siemens AG.

The superconducting magnet, which is about four meters long and weighs 57 metric tons, came to Jülich by heavy-load delivery from Oxford, England. It was unloaded by crane during the course of the day and placed in a new building, which had been specifically constructed to house it. Some 870 tons of steel provide shielding for the magnetic field to the outside in a room of approx. 150 square meters to ensure that the magnet can take up operations in the weeks to come without any hazard. Once the device is completely installed, it will have the only bore in existence with a diameter of 90 centimeters. "This will provide us with enough space to give study subjects specific tasks that require pressing buttons or moving a joystick to observe their brain functions in digital images," explained Prof. Shah.

The new 9.4-Tesla MRI represents a giant leap from 1.5T or 3T devices that are typically available in clinical settings. The higher the magnetic field, the better the image quality, which makes it easier to distinguish various types of tissue. The system will even allow for tracking the behavior of individual cells in live organisms, which are marked with the help of contrast medium.

The combination with a PET unit, which is also projected to be installed in 2009, makes the new device truly unique. It allows for monitoring metabolic processes and makes it feasible to study sequences occurring at receptors, which are responsible for the communication between brain cells. PET images are relatively unfocused on their own and yield very inaccurate local information. However, the combination of MRI and PET makes a perfect team that supplies scientists with anatomically detailed images and allows for the analysis of the ongoing molecular mechanisms at the same time. The combined examination makes it feasible to study the brain from various perspectives in the same state, which would be impossible if the MRI and PET images were to be taken in sequence.

The expertise of the Jülich team in imaging techniques is boosted by its close cooperation with the industry and the nearby university clinics, especially the RWTH Aachen clinic in the JARA Brain Group. This ensures that the basic research from Jülich quickly finds practical applications, which translates into a dramatic shortening of the path from scientific insight to patient benefit. Siemens currently is the leading provider of high-field magnetic resonance imaging, and is the world′s only manufacturer to combine magnetic resonance imaging (MRI) with a field strength of 9.4 Tesla with positron emission tomography (PET). More than half of the approximately 30 systems in the 7 Tesla range currently installed around the world are Siemens systems.

Further Information: Combined 9.4-tesla-MR-PET


596_PREV_9_4_tesla_anl_001_jpg

Photo: Forschungszentrum Jülich


596_PREV_9_4_tesla_anl_003_jpg

Photo: Forschungszentrum Jülich


596_PREV_9_4_tesla_anl_005_jpg

Photo: Forschungszentrum Jülich


596_PREV_9_4_tesla_anl_010_jpg

Photo: Forschungszentrum Jülich


596_PREV_9_4_tesla_anl_012_jpg

Photo: Forschungszentrum Jülich


596_PREV_9_4_tesla_anl_015_jpg

Photo: Forschungszentrum Jülich


596_PREV_9_4_tesla_anl_016_jpg

Photo: Forschungszentrum Jülich


596_PREV_9_4_tesla_anl_017_jpg

Photo: Forschungszentrum Jülich

Siemens Healthcare is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reportedsales of EUR 9.85 billion, orders of EUR 10.27 billion, and group profit of EUR 1.32 billion. Siemens Healthcare Website

Contact:

Holger ReimSiemens AG
Healthcare Sector
Corporate Communications, Media Relations
Henkestr. 12791052 Erlangen
Germany
Phone: 49 (9131) 84-3473
Fax: 49 (9131) 84-3047
holger.reim@siemens.com


Press contact:

Annette Stettien
Phone 02461 61-2388
E-Mail: a.stettien@fz-juelich.de


Servicemeu

Homepage